Charleston, South Carolina

Charleston has emerged as a premier life sciences hub in the Southeastern United States, driven by a $20.1 billion statewide economic impact and a rapidly growing talent pipeline.

The ecosystem is anchored by the Medical University of South Carolina (MUSC), a leader in academic research and healthcare innovation that attracts nearly $300 million in annual funding for breakthroughs in oncology, neuroscience and regenerative medicine.

This research excellence fuels a thriving biotechnology sector, where homegrown startups like CharlestonPharma and Elastrin Therapeutics pioneer novel monoclonal antibodies and cardiovascular therapies.

The region is equally renowned for its medical device manufacturing and healthtech landscape, hosting global headquarters and R&D facilities for industry leaders such as Belimed and Hillrom.

Strategic biopharmaceutical operations and contract development and manufacturing organizations (CDMOs) benefit from Charleston’s world-class logistics infrastructure, including the Port of Charleston.

Collaborative initiatives through SCbio foster a "plug-and-play" environment for clinical trials and digital health ventures, positioning the city as a top destination for life science investment.

With a specialized workforce and a focus on medical imaging and molecular diagnostics, Charleston seamlessly blends historic charm with cutting-edge bioscience advancements.